Recombinant Rat CCL24 Protein

CCL24, also known as eotaxin-2, is a chemokine that plays a crucial role in the immune system, particularly in the recruitment of eosinophils and T-helper type 2 (Th2) cells to sites of inflammation. Elevated levels of CCL24 have been associated with various allergic and inflammatory diseases, such as asthma, allergic rhinitis, and atopic dermatitis, highlighting its potential as a therapeutic target. Research into the recombinant production of CCL24 protein has gained momentum, driven by the need for standardized reagents to study its functional mechanisms and interactions in human physiology. The development of CCL24 recombinant protein allows for more precise in vitro and in vivo investigations into its role in immune responses and disease pathology. Furthermore, understanding the signaling pathways mediated by CCL24 could provide insights into novel therapeutic strategies aimed at controlling eosinophilic inflammation and allergic reactions. The elucidation of CCL24's structural and functional properties is critical for the development of inhibitors or modulators that could effectively manipulate its activity in pathological conditions, ultimately contributing to improved treatment options for patients suffering from immune-mediated disorders. Thus, the research surrounding CCL24 recombinant protein not only enhances our understanding of chemokines in immune regulation but also holds significant promise for therapeutic advancements in treating related diseases.